$0.02 (1.61%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Erwin HaitzmannPeter Hoetzinger |
| Industry | Gambling, Resorts & Casinos |
| Sector | Consumer Cyclical |
| Current Symbol | CNTY |
| CUSIP | 156492100 |
| CIK | 0000911147 |
| Web | https://www.cnty.com |
| Phone | 719 527 8300 |
| Currency | USD |
| Employees | 3756 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -9.37 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.22 |
| Quick Ratio | 1.18 |
| Cash Ratio | 0.77 |
Sales & Book Value
| Annual Sales | $572.98M |
| Price / Sales | 0.06 |
| Cash Flow | -0.28 |
| Price / Cash Flow | -4.49 |
| Price / Book | -0.31 |
Price Target and Rating
| Average Stock Price Forecast | $2.50 |
| High Stock Price Forecast | $2.50 |
| Low Stock Price Forecast | $2.50 |
| Forecast Upside/Downside | -49.60% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 12 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-2.04 |
| Trailing P/E Ratio | -0.65 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-61.42M |
| Net Margin | -9.88% |
| Pretax Margin | -8.04% |
| Return on Equity | 68.93% |
| Return on Assets | -5.10% |
Financials Score
| AltmanZ Score | 0.45 |
| Piotroski Score | 5.00 |
| Working Capital | 17.39M |
| Total Assets | 1.12B |
| Ebit | 58.07M |
| Market Cap | 34.89M |
| Total Liabilities | 1.15B |
About Century Casinos, Inc. (NASDAQ:CNTY) Stock
Century Casinos, Inc. operates as a casino entertainment company in the United States, Canada, and Poland. The company develops and operates gaming establishments, as well as related lodging, restaurant, and horse racing including off-track betting; and entertainment facilities. Century Casinos, Inc. was founded in 1992 and is based in Colorado Springs, Colorado. ...
2026-07-09 08:00:00
PHILADELPHIA, July 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced that its abstracts have been accepted for oral presentations at two upcoming scientific congresses:
Despite Fast-paced Momentum, Century Casinos (CNTY) Is Still a Bargain Stock
2026-06-19 09:56:19
Century Casinos (CNTY) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is Century Casinos (CNTY) Outperforming Other Consumer Discretionary Stocks This Year?
2026-06-17 10:40:32
Here is how Century Casinos (CNTY) and Carter's (CRI) have performed compared to their sector so far this year.
2026-06-08 16:05:00
PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced the presentation of new preclinical data from CNTY-813, Century's iPSC-derived islet replacement therapy engineered with Allo-Evasion™ 5.0, in an oral presentation at the American Diabetes Association (ADA) 86th Scientific Sessions in New Orleans, Louisiana.
Century Casinos Announces Appointment to Top Leadership Role in the United States
2026-05-13 16:30:00
COLORADO SPRINGS, Colo., May 13, 2026 /PRNewswire/ -- Century Casinos, Inc. (the "Company" or "Century Casinos") (Nasdaq Capital Market®: CNTY) announced today that Lyle Randolph, a long-term regional Vice President and General Manager of the Company, will take over as Executive Vice President of Operations for the United States.
Century Casinos, Inc. (CNTY) Q1 2026 Earnings Call Transcript
2026-05-08 16:21:19
Century Casinos, Inc. (CNTY) Q1 2026 Earnings Call Transcript
Century Casinos (CNTY) Reports Q1 Loss, Lags Revenue Estimates
2026-05-08 08:11:18
Century Casinos (CNTY) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.67 per share a year ago.
Century Casinos, Inc. Announces First Quarter 2026 Results
2026-05-08 06:00:00
All-Time Record First Quarter Net Operating Revenue COLORADO SPRINGS, Colo., May 8, 2026 /PRNewswire/ -- Century Casinos, Inc. (the "Company", "we", "us", or "our") (Nasdaq Capital Market®: CNTY) today announced its financial results for the three months ended March 31, 2026.
Frequently Asked Questions
What is the current Century Casinos, Inc. (CNTY) stock price?
Century Casinos, Inc.(NASDAQ:CNTY) stock price is $1.26 in the last trading session. During the trading session, CNTY stock reached the peak price of $2.85 while $1.23 was the lowest point it dropped to. The percentage change in CNTY stock occurred in the recent session was 1.61% while the dollar amount for the price change in CNTY stock was $0.02.
CNTY's industry and sector of operation?
The NASDAQ listed CNTY is part of Gambling, Resorts & Casinos industry that operates in the broader Consumer Cyclical sector.
Who are the executives of CNTY?
Andreas Terler
| MD of Century Resorts Management GmbH & Executive Vice President of Operations United States
Timothy Wright
| Chief Accounting Officer & Corporate Controller
Lyle Randolph
| Executive VP of Operations (US)
Erwin Haitzmann
| Chairman & Co-CEO
Margaret Stapleton
| Chief Financial Officer & Corporate Secretary
How many employees does CNTY have?
Number of CNTY employees currently stands at 3756. CNTY operates from 455 East Pikes Peak Avenue, Colorado Springs, CO 80903, US.
Link for CNTY official website?
Official Website of CNTY is: https://www.cnty.com
How do I contact CNTY?
CNTY could be contacted at phone #719 527 8300 and can also be accessed through its website. CNTY operates from 455 East Pikes Peak Avenue, Colorado Springs, CO 80903, US.
How many shares of CNTY are traded daily?
The average number of CNTY shares traded daily for last 3 months was 71.78K.
What is the market cap of CNTY currently?
The market value of CNTY currently stands at $35.45M with its latest stock price at $1.26